Literature DB >> 28863817

Regulation of P2X Purinergic Receptor Signaling by Cholesterol.

Ruth D Murrell-Lagnado1.   

Abstract

P2X receptors are cation-selective channels that are activated by the binding of extracellular ATP. They have a high permeability to Ca2+, Na+, and K+ and are expressed widely throughout the nervous, immune, cardiovascular, skeletal, gastrointestinal, respiratory, and endocrine systems. Seven mammalian subtypes of P2X receptor subunits have been identified, P2X1-7, and those that function as homotrimeric receptors (P2X1, 2, 3, 4, and 7) are targeted to lipid rafts, although they show limited resistance to solubilization by Triton X-100. Recent crystal structures of P2X3 and P2X4 receptors have provided considerable high-resolution information about the architecture of this family of receptors and yet the molecular details of how they are regulated by cholesterol are unknown. Currents mediated by the P2X1-4 receptors are either inhibited or relatively insensitive to cholesterol depletion, but there is no clear evidence to support the direct binding of cholesterol to these receptors. In contrast, the activity of the low-affinity, proinflammatory P2X7 receptor is potentiated by cholesterol depletion and regions within the proximal C-terminus play an important role in coupling changes in cholesterol to the gating of the pore. Based upon our understanding of the lipid signaling events that are triggered downstream of P2X7 receptor activation, a change in the levels of cholesterol may contribute to the sensitization of receptor currents and the dilation of the pore that occurs following prolonged, high-level stimulation. This chapter focuses on the regulation of P2X7 receptor signaling by cholesterol and our current understanding of the mechanisms that underlie this.
© 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cholesterol; Crystal structures; Inflammation; Lipid rafts; P2X purinergic receptors; P2X7; Palmitoylation

Mesh:

Substances:

Year:  2017        PMID: 28863817     DOI: 10.1016/bs.ctm.2017.05.004

Source DB:  PubMed          Journal:  Curr Top Membr        ISSN: 1063-5823            Impact factor:   3.049


  19 in total

1.  P2X7 receptor activation increases expression of caveolin-1 and formation of macrophage lipid rafts, thereby boosting CD39 activity.

Authors:  Luiz Eduardo Baggio Savio; Paola de Andrade Mello; Stephanie Alexia Cristina Silva Santos; Júlia Costa de Sousa; Suellen D S Oliveira; Richard D Minshall; Eleonora Kurtenbach; Yan Wu; Maria Serena Longhi; Simon C Robson; Robson Coutinho-Silva
Journal:  J Cell Sci       Date:  2020-03-06       Impact factor: 5.285

2.  Methods for Studying Cholesterol-Dependent Regulation of P2X7 Receptors.

Authors:  Ruth D Murrell-Lagnado; Toshimitsu Kawate
Journal:  Methods Mol Biol       Date:  2022

3.  Full-Length P2X7 Structures Reveal How Palmitoylation Prevents Channel Desensitization.

Authors:  Alanna E McCarthy; Craig Yoshioka; Steven E Mansoor
Journal:  Cell       Date:  2019-10-03       Impact factor: 41.582

Review 4.  Lipid rafts in glial cells: role in neuroinflammation and pain processing.

Authors:  Yury I Miller; Juliana M Navia-Pelaez; Maripat Corr; Tony L Yaksh
Journal:  J Lipid Res       Date:  2019-12-20       Impact factor: 5.922

5.  Molecular Dynamics Simulations of Kir2.2 Interactions with an Ensemble of Cholesterol Molecules.

Authors:  Nicolas Barbera; Manuela A A Ayee; Belinda S Akpa; Irena Levitan
Journal:  Biophys J       Date:  2018-08-23       Impact factor: 4.033

Review 6.  Non-nucleotide Agonists Triggering P2X7 Receptor Activation and Pore Formation.

Authors:  Francesco Di Virgilio; Anna L Giuliani; Valentina Vultaggio-Poma; Simonetta Falzoni; Alba C Sarti
Journal:  Front Pharmacol       Date:  2018-02-01       Impact factor: 5.810

7.  The P2X7 receptor forms a dye-permeable pore independent of its intracellular domain but dependent on membrane lipid composition.

Authors:  Akira Karasawa; Kevin Michalski; Polina Mikhelzon; Toshimitsu Kawate
Journal:  Elife       Date:  2017-09-18       Impact factor: 8.140

Review 8.  To inhibit or to boost the ATP/P2RX7 pathway to fight cancer-that is the question.

Authors:  Serena Janho Dit Hreich; Jonathan Benzaquen; Paul Hofman; Valérie Vouret-Craviari
Journal:  Purinergic Signal       Date:  2021-08-04       Impact factor: 3.765

9.  New Insights Into Permeation of Large Cations Through ATP-Gated P2X Receptors.

Authors:  Laurie Peverini; Juline Beudez; Kate Dunning; Thierry Chataigneau; Thomas Grutter
Journal:  Front Mol Neurosci       Date:  2018-07-31       Impact factor: 5.639

Review 10.  P2RX7 Purinoceptor as a Therapeutic Target-The Second Coming?

Authors:  Chris N J Young; Dariusz C Górecki
Journal:  Front Chem       Date:  2018-06-28       Impact factor: 5.221

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.